| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev & Strategy | Restricted stock units | 24.3K | $864K | $35.54 | Mar 5, 2025 | Direct |
| AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev & Strategy | Stock options (right to buy) | 55.4K | Mar 5, 2025 | Direct | ||
| CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Aug 19, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRGX | CARGO Therapeutics, Inc. | Aug 19, 2025 | 2 | $0 | 4 | Aug 19, 2025 | Director |
| CRGX | CARGO Therapeutics, Inc. | Jun 18, 2025 | 1 | $0 | 4 | Jun 23, 2025 | Director |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 5, 2025 | 2 | $0 | 4 | Mar 7, 2025 | Chief Corp Dev & Strategy |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 5, 2025 | 0 | $0 | 3 | Mar 7, 2025 | Chief Corp Dev & Strategy |
| CRGX | CARGO Therapeutics, Inc. | Jun 4, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
| CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 1 | $0 | 4 | Nov 13, 2023 | Director |
| CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 0 | $0 | 3 | Nov 9, 2023 | Director |